Well, in many concalls management didn’t share exact nos. about RUBY-FILL siting secrecy in limited competition arena…its a duopoly market and Bracco fought tooth & nail to protect there turf…last yr. jubilant balance sheet shows a few million USD spent as a legal fees which shows there is booty on the table. Cardiac Positron Emission Tomography (PET) imaging is the gold standard diagnostic test in nuclear cardiology…The average PET scan cost in the United States is $5,750… Exact RUBY-FILL cost not able to find though…
Came across this2013 article filed by POSITRON to the SEC…
https://www.sec.gov/Archives/edgar/data/844985/000114420413004738/v333310_ex99-1.htm
One para from the above article which emphasizes duopoly…
- RADIOPHARMACEUTICALS: MANUFACTURING, PROCESSING & DISTRIBUTION
Positron is negotiating a strategic alliance with Jubilant DraxImage Inc. (JDI), an Sr-82/Rb-82 generator manufacturer, whose generator and related infusion cart is currently in the FDA approval process. Upon FDA approval, Positron expects to market and distribute the first and only alternative to Bracco’s Cardiogen-82 generator. Positron will supply JDI with Sr-82 for their generator production. Positron intends to offer generators to their current and future Attrius customers and will introduce new customers to JDI’s generator utilizing Positron’s current nuclear cardiology network. Initial efforts will be focused on North America.
Also, as per management’s concall comments ,they have appointed distibutor for RUBY FILL for European Economic Area (EEA).
So, not able to give exact no. but should get rough idea I hope…